Drug recall · March 9, 2022
Moxifloxacin Ophthalmic Solution USP 0.5% recall
Why: Failed impurities/degradation specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Dist. By Aurobindo Pharma USA, Inc. East Windsor, NJ 08520, NDC 72189-076-05
- Lots / codes
Lot#: 18JA2218 Exp. 6/30/23; 20DE2104 Exp. 6/30/23; 08NO2111 Exp. 6/30/23
- Quantity
- 44 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- Florida
- Initiated
- February 17, 2022 · Voluntary: Firm initiated
- Classified
- February 25, 2022
- Reported
- March 9, 2022
- Ended
- October 4, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Moxifloxacin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.